#VisualAbstract: Molnupiravir improves outcomes in non-hospitalized COVID-19 patients
1. In coronavirus disease 2019 (COVID-19) patients, molnupiravir was associated with earlier and...
Read MoreJun 30, 2022
1. In coronavirus disease 2019 (COVID-19) patients, molnupiravir was associated with earlier and...
Read MoreJun 29, 2022
1. New-onset atrial fibrillation following hospitalization for community acquired pneumonia was...
Read MoreJun 29, 2022
1. In idiopathic pulmonary fibrosis (IPF) patients, phosphodiesterase 4 inhibitor BI 1015550...
Read MoreJun 29, 2022
1. In this randomized controlled trial, among 457 participants with prodromal to mild Alzheimer’s...
Read MoreJun 2, 2022
1. In patients with stable chest pain and intermediate pretest probability of coronary artery...
Read MoreJun 2, 2022
1. This randomized controlled trial found that high dose methylprednisolone for 6-9 months reduced...
Read MoreMay 20, 2022
1. Physical activity was significantly associated with a decreased incidence of all-cause dementia...
Read MoreMay 20, 2022
Click to read this study in the Journal of Clinical Oncology.
Read MoreMay 19, 2022
Click to read this study in Journal of Clinical Oncology.
Read MoreMay 5, 2022
Click to read this study in The Lancet Oncology.
Read MoreMay 4, 2022
Click to read this study in The Lancet Oncology.
Read MoreApr 29, 2022
1. Neoadjuvant nivolumab plus chemotherapy led to a longer event-free survival and higher...
Read MoreApr 28, 2022
1. The risk of hospitalization and death was lower among cases infected with Omicron variant...
Read MoreApr 28, 2022
Click to read this study in The Lancet Oncology.
Read More